RBIO-101

N/A

Report date: 2023/10/26 16:55:25

Base Information

Drug NameRBIO-101
Drug Alias Namerecombinant adeno-associated virus vector encoding human CYP4V2 proteinRBIO-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionCYP4V2 gene transference
TargetsCytochrome P450 4V2
Therapy Area/IndicationsRetinal Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReflection Biotechnologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRetinal Dystrophies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A